Clinical Trials
All Clinical Trials - Page 41 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT02905682Phase 3Completed
Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Female Subjects
Desmopressin
- NCT02904759Phase 3Completed
Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Male Subjects
Desmopressin
- NCT02877355Phase 1Completed
Investigation of the Effect of Upper Gastrointestinal Disease on the Pharmacokinetics of Oral Semaglutide in Subjects With Type 2 Diabetes.
Semaglutide
- NCT02805790Phase 2Completed
Safety, Tolerability, Efficacy of MTP-131 for Treatment of Mitochondrial Disease in Subjects From the MMPOWER Study
Elamipretide
- NCT02870231Phase 1Completed
Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With Obesity
Liraglutide
- NCT02843399N/ACompleted
Economic Outcomes of EQW (Exenatide Once Weekly) vs. IG (Insulin Glargine) in T2D Patients Who Are New to Injectable Therapy
Exenatide
- NCT02863419Phase 3Completed
Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus
Semaglutide
- NCT02863328Phase 3Completed
Efficacy and Safety of Oral Semaglutide Versus Empagliflozin in Subjects With Type 2 Diabetes Mellitus
Semaglutide
- NCT02312089Phase 4Unknown
GnRHa for Luteal Phase Support in GnRH Antagonist Protocol Cycles
Gonadorelin
- NCT05945407N/ARecruiting
Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer
Gonadorelin
- NCT04325581Phase 3Completed
Laparocopic Sleeve Gastrectomy With or Without Liraglutide in Obese Patients
Liraglutide
- NCT02734641N/ACompleted
Does Increase in Appetite After Iron Treatment Induced by Ghrelin Hormone
Ghrp-6
- NCT02895672N/ACompleted
GLP-1/Basal Insulin Combination Therapy
Liraglutide
- NCT02846233N/ACompleted
Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy?
Dulaglutide
- NCT02750410Phase 4Completed
A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes
Dulaglutide
- NCT03002675Phase 4Unknown
Exenatide and Brown Adipose Tissue
Exenatide
- NCT02838589Phase 2Completed
The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Non-stroke Volunteers
Exenatide
- NCT02829502Phase 2Unknown
The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Stroke
Exenatide
- NCT02767596Phase 4Terminated
Evaluation of Lixisenatide Efficacy in Diabetes Mellitus Type 2 With Failure of Other GLP-1 Analog
Lixisenatide
- NCT02787551Phase 3Completed
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period
Liraglutide
- NCT03791736N/ATerminated
Evaluation of Impact of Sandostatin® Injection Before Axillary Clearance on Lymphocele Formation
Octreotide
- NCT02758431N/ACompleted
Cardiovascular Outcomes of Low Testosterone
Gonadorelin
- NCT02865681N/ACompleted
Protocol to Minimize Injections and Blood Draws for Women Undergoing in Vitro Fertilization
Gonadorelin
- NCT03734627N/ACompleted
Gastrointestinal Nutrient Transit and Enteroendocrine Function After Upper Gastrointestinal Surgery
Octreotide
- NCT02845219Phase 1Completed
A Trial Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Ethinylestradiol and Levonorgestrel in an Oral Contraceptive Combination Drug in Healthy Postmenopausal Females
Semaglutide
- NCT02806414Phase 1/Phase 2Completed
Evaluation of the Inhibitory Effects of Topical Ivermectin on Markers of Rosacea Specific Inflammation.
Ll-37
- NCT02783196N/AUnknown
Effect of Liraglutide on Clock Genes
Liraglutide
- NCT02975297Phase 1/Phase 2Completed
Exenatide Once Weekly for Smoking Cessation
Exenatide
- NCT02691078Phase 2Completed
Validation of 99mTc- EDDA - HYNIC -TOC Kits for Diagnosis of Neuroendocrine Tumors
Octreotide
- NCT01587222Phase 2Withdrawn
Midodrine, Octreotide and Albumin: Impact on Renal Function of Patients With Liver Cirrhosis and Renal Failure
Octreotide
- NCT02698410Phase 2Completed
Efficacy and Safety of Lanreotide Autogel (ATG) in Combination With Temozolomide in Subjects With Thoracic Neuroendocrine Tumors.
Lanreotide
- NCT02807233N/ACompleted
Lanreotide Autogel 120 mg at Extended Dosing Intervals (>4 Weeks) in Acromegalic Subjects
Lanreotide
- NCT02809105Phase 3Completed
A Study of Oral Dosing of ASP0456 in Patients With Chronic Constipation
Linaclotide
- NCT02682381Phase 3Completed
Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition
Teduglutide
- NCT02795858Phase 2Completed
A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors
Octreotide
- NCT02773381Phase 1Completed
A Trial Investigating the Effect of Oral Semaglutide Compared With Placebo on Postprandial Glucose and Triglyceride Metabolism, Energy Intake, Appetite Sensations and Gastric Emptying in Subjects With Type 2 Diabetes
Semaglutide
- NCT05762744Phase 1Terminated
Pharmacogenomics of GLP1 Receptor Agonists
Exenatide
- NCT04857801N/ACompleted
Teduglutide in Short Bowel Syndrome Patients
Teduglutide
- NCT03017768N/ACompleted
The Effect of Acute Tryptophan Depletion (ATD) on Esophageal Sensitivity in Healthy Volunteers
KPV
- NCT02736591Phase 3Unknown
Dehydroepiandrosterone Versus Growth Hormone in Women Undergoing ICSI With Expected Poor Ovarian Response
Sermorelin
- NCT02788747Phase 2Completed
Effect of Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Reduced Ejection Fraction
Elamipretide
- NCT03018314N/ACompleted
Serum Kisspeptin Levels in Infertile Women
Kisspeptin
- NCT02592746Phase 2Unknown
A Study of Palbociclib With Exemestane Plus GnRH Versus Capecitabine in Premenopausal Women With HR+ MBC
Gonadorelin
- NCT02653092N/AActive Not Recruiting
Reprometabolic Syndrome Mediates Subfertility in Obesity
Gonadorelin
- NCT02718950Phase 3Unknown
Influence of Liraglutide, a GLP-1 Receptor Agonist, on Brown Adipose Tissue (BAT) Activity in Humans
Liraglutide
- NCT02535299Phase 4Unknown
Par-4 and Telomere-telomerase System in Type 2 Diabetes Patients Who Received GLP-1 or Metformin Treatment
Liraglutide
- NCT02811484Phase 4Withdrawn
Efficacy of Exenatide-LAR and Dapagliflozin in Overweight/Obese, Insulin Treated Patients With Type 2 Diabetes
Exenatide
- NCT02788578N/ATerminated
A Retrospective Data Analysis of Therapy With PRRT Combined With Lanreotide Autogel® for Neuroendocrine Tumours
Lanreotide
- NCT02781493Phase 4Unknown
Efficacy of Prucalopride Plus Polyethylene Glycol in Bowel Preparation for Colonoscopy
Linaclotide
- NCT02773368Phase 3Completed
A Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine (IGlar) as add-on Therapy to SGLT2i in Subjects With Type 2 Diabetes Mellitus
Liraglutide